Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Multifunctional SnO2/SnS2/CdSe heterojunction coupled with CuO nanoenzyme-regulating synergistic strategy enable multimodal biosensing for breast cancer genes.

Created on 07 Oct 2026

Authors

He Wu, Jianwei Zhou, Wenyuan Zhu, Guifen Jie

Published in

Analytica chimica acta. Volume 1423. Pages 346195. Nov 15, 2026. Epub Aug 28, 2026.

Abstract

Multimodal detection significantly enhanced detection accuracy in complex biological matrices. In this work, a high-efficiency multimodal biosensor is proposed based on multifunctional SnO2/SnS2/CdSe QDs heterojunction and CuO nanoenzyme-regulating synergistic strategy, which achieves ultra-sensitive and specific detection of breast cancer-related BRCA1 gene. A high-performance photoelectrochemical (PEC) SnO2/SnS2/CdSe QDs heterojunction was constructed for the first time, which effectively enhances the light absorption capability and photogenerated charge separation efficiency. The heterojunction yields a PEC signal approximately 3.75-fold higher than that of pure SnO2/SnS2 and 11.3-fold higher than that of CdSe QDs, realizing stable PEC and electrochemiluminescence (ECL) dual signals. Notably, CuO nanoenzyme with intrinsic oxidase-like activity are introduced onto the sensing interface through target-induced amplification strategies, serving as multifunctional signal regulatory units. The CuO nanoenzyme can not only catalyze the oxidation of ascorbic acid but also trigger the ECL resonance energy transfer effect. This dual functionality enables the simultaneous "shutdown" of PEC and ECL signals and "activation" of fluorescence signals, constructing a self-verifiable triple-modal sensing platform for BRCA1 detection. The developed biosensor has been successfully applied to the quantitative detection of BRCA1 in human serum samples. This report offered a promising and versatile platform for early clinical diagnosis of breast cancer and detection of other important disease biomarkers.

PMID:
42838645
Bibliographic data and abstract were imported from PubMed on 07 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement